key: cord-0909180-j205224b
authors: Scorza, Fulvio Alexandre; Finsterer, Josef
title: A selected view does not represent the real world of SARS-CoV-2 vaccination outcomes
date: 2021-11-25
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2021.11.013
sha: 9f322d01989c28fe7074ee3a7d9d669f2eb5b0b0
doc_id: 909180
cord_uid: j205224b

nan

Fulvio Alexandre Scorza [1] , Josef Finsterer, MD [2] , [ [1] . Four diagnoses, respectively symptoms were used as outcome parameters, Bell's palsy, herpes zoster, Guillain-Barre syndrome (GBS), and numbness and tingling [1] . It was found that numbness and tingling occurred more frequently among vaccinees than in controls but not the other three outcome variables. [1] . It is the merit of this study, that at least a small spectrum of possible adverse reactions were addressed, but concerns remain. One limitation of the study is that the endpoints were identified by visit diagnoses. The authors themselve admit that this method of data acquisition might lead to "partial or inaccurate" diagnoses [1] . Diagnosing GBS, for example, requires application of the Brighton criteria. Application of the Brighton criteria implies that patients with suspected GBS undergo cerebrospinal fluid (CSF) investigations and nerve conduction studies (NCSs) in addition to history and clinical exam. It would be interesting to know if the patient with GBS in the investigated cohort fulfilled the Brighton criteria or not. Another limitation is that the cause of sensory symptoms was not sufficiently explored, which admittedly, is inherent to the retrospective design. Anyhow, attributing sensory symptoms of the face to anxiety is unsupported by the presented data as various differentials were not excluded. Since sensory symptoms (numbness and tingling) were "mainly on one side of the face", small fiber neuropathy (SFN) is rather unlikely the cause of these symptoms given the fact that SFN usually manifests in the feet and the hands [2] . Attributing sensory symptoms of the face to processing of reports in mass media about a suspected association between SARS-CoV-2 vaccinations and facial palsy is misleading as sensory abnormalities of the face rather suggest affection of the trigeminal than the facial nerve. Since mono-or polyneuritis cranialis is a confirmed complication of SARS-CoV-2 infections [3] and since SARS-CoV-2 vaccinations imitate the infection, it is warranted that mononeuritis of a clinically affected cranial nerve is appropriately excluded. Sensory disturbances in the face can be, for example, the initial manifestation of a zoster infection. A further limitation is that 41% of the eligible vaccinees were excluded for reasons of matching. Though inclusion of these 41% might bias the evaluation, valuable information could be achieved as well. Particularly, it would be interesting to know if comparison of the entire cohort of eligible vaccines with the control cohort results in conclusions at variance from those J o u r n a l P r e -p r o o f reported. Matching for the number of comorbidities but not the type of comorbidity is a bias as well. Selection of only four outcome parameters "of concern" was established by identifying outcomes by clinical visits. However, more than four outcome parameters can be assessed upon clinical visits. Considering only the neurological side effects of SARS-CoV-2 vaccinations, the spectrum of adverse reactions is much broader, including headache, myalgia, venous sinus thrombosis (VST), transverse myelitis, SFN, immune encephalitis, and others in addition to GBS and facial palsy. Headache is by far the most prevalent of the neurological side effects and can be easily assessed by clinical visits as well as myalgia. We should know why only four outcome measures were selected although the MHMO database offered more options. The term Bell's palsy is inaccurate. Bell's palsy stands for facial nerve palsy of undetermined cause. If facial palsy is attributed to a reaction against the vaccination, the term Bell's palsy should be avoided. Overall, the interesting study has limitations which challenge the results and their interpretation. Real world data rather indicate that the spectrum of side effects to any of the commercially available SARS-CoV-2 vaccinations is broader than anticipated, underreported, and played down. Side effects need to be thoroughly elaborated to draw more real pictures than those frequently sold. Real world is more unsafe than its propagated image.

Ethical approval and consent to participate: not applicable Consent for Publication: not applicable Availability of data and material: all data reported are available from the corresponding author Competing interests: none Funding: none received

Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study

Current View of Diagnosing Small Fiber Neuropathy

COVID-19 associated cranial nerve neuropathy: A systematic review